- N-Me-N-bis-PEG4
-
- $58.00 / 5mg
-
2026-01-04
- CAS:2055046-22-3
- Min. Order:
- Purity:
- Supply Ability: 10g
- N-Me-N-bis(PEG3-OH)
-
- $0.00 / 500mg
-
2025-06-07
- CAS:2055046-22-3
- Min. Order: 500mg
- Purity: >95.00%
- Supply Ability: 500mg
|
| | N-Me-N-(PEG3-OH)2 Basic information |
| Product Name: | N-Me-N-(PEG3-OH)2 | | Synonyms: | N-Me-N-(PEG3-OH)2;N-Me-N-bis(PEG3-OH);3,6,9,15,18,21-Hexaoxa-12-azatricosane-1,23-diol, 12-methyl- | | CAS: | 2055046-22-3 | | MF: | C17H37NO8 | | MW: | 383.48 | | EINECS: | | | Product Categories: | | | Mol File: | 2055046-22-3.mol |  |
| | N-Me-N-(PEG3-OH)2 Chemical Properties |
| Boiling point | 482.2±40.0 °C(Predicted) | | density | 1.096±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C, protect from light | | form | Liquid | | pka | 14.06±0.10(Predicted) | | color | Colorless to light yellow |
| | N-Me-N-(PEG3-OH)2 Usage And Synthesis |
| Description | N-Me-N-bis(PEG3-OH) is a branched PEG linker with two terminal hydroxyl groups. | | Uses | N-Me-N-bis-PEG4 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | N-Me-N-(PEG3-OH)2 Preparation Products And Raw materials |
|